Letrozole SanoSwiss 2,5 mg plėvele dengtos tabletės
C4391025
Phase 2 small_molecule active
Quick answer
Letrozole SanoSwiss 2,5 mg plėvele dengtos tabletės for HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active